The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations, is intended to address the high level of individualisation of such devices by grouping them under a common identifier in EUDAMED. This approach is designed to ease the regulatory burden by avoiding the proliferation of identifiers for similar devices, while ensuring traceability and compliance with the MDR. MDCG 2025-7 clarifies the applicable timelines, the labelling obligations for the Master UDI-DI, the requirement to use the UDI/Device registration module of EUDAMED, and how these obligations interact in practice.
What does this mean for you?
Manufacturers of these devices should review their UDI strategies to ensure compliance with the new grouping approach. Early planning and system updates may be needed to meet labelling and registration obligations efficiently.
About the Author
MSc Biomedical Sciences · Business Unit Manager RA IVD & Representative Services
With over 20 years of experience in the diagnostics industry, Kirsten leads the IVD Regulatory Affairs business unit at QbD Group, guiding regulatory strategy and compliance across all IVDs with a focus on companion diagnostics.
Navigate Regulatory Complexity with Confidence
Navigate complex regulatory landscapes with expert guidance across pharmaceuticals, medical devices, and IVD.
Read moreSubscribe to the latest updates in life science
Expert perspectives delivered to your inbox — pick your interests.
No spam, ever. Unsubscribe anytime.
